...
首页> 外文期刊>BMC Gastroenterology >Combined sedation with midazolam/propofol for gastrointestinal endoscopy in elderly patients
【24h】

Combined sedation with midazolam/propofol for gastrointestinal endoscopy in elderly patients

机译:镇静联合咪达唑仑/丙泊酚在老年患者胃肠道内窥镜检查中的应用

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Although gastrointestinal endoscopy with sedation is increasingly performed in elderly patients, data on combined sedation with midazolam/propofol are very limited for this age group. Methods We retrospectively analyzed 454 endoscopic procedures in 347 hospitalized patients ≥ 70 years who had received combined sedation with midazolam/propofol. 513 endoscopic procedures in 397 hospitalized patients Results Elderly patients had a higher level of co-morbidity and needed lower mean propofol doses for sedation. We observed no major complication and no difference in the number of minor complications. The procedure-associated mortality was 0%; the 28-day mortality was significantly higher in the elderly (2.9% vs. 1.0%). Conclusions In this study on elderly patients with high level co-morbidity, a favourable safety profile was observed for a combined sedation with midazolam/propofol with a higher sensitivity to propofol in the elderly.
机译:背景技术尽管老年患者越来越多地采用胃肠道内窥镜进行镇静,但该年龄组与咪达唑仑/丙泊酚联合镇静的数据非常有限。方法我们回顾性分析了347例≥70岁的住院患者的454例内镜手术,这些患者接受了咪达唑仑/丙泊酚联合镇静。结果397例住院患者接受了513例内窥镜检查结果结果老年患者的合并症水平较高,需要较低的异丙酚平均镇静剂量。我们没有观察到大的并发症,并且次要并发症的数量也没有差异。与手术相关的死亡率为0%;老年人的28天死亡率显着更高(2.9%比1.0%)。结论在这项针对高合并症的老年患者的研究中,观察到咪达唑仑/丙泊酚联合镇静剂对老年人的丙泊酚敏感性更高,其安全性良好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号